Cargando…
Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review
BACKGROUND: Refractory status epilepticus (RSE) represents a serious medical condition requiring early and targeted therapy. Given the increasing number of elderly or multimorbid patients with a limitation of life-sustaining therapy (LOT) or within a palliative care setting (PCS), guidelines-oriente...
Autores principales: | Willems, Laurent M., Bauer, Sebastian, Jahnke, Kolja, Voss, Martin, Rosenow, Felix, Strzelczyk, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316215/ https://www.ncbi.nlm.nih.gov/pubmed/32705422 http://dx.doi.org/10.1007/s40263-020-00747-z |
Ejemplares similares
-
Correction to: Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life‑Sustaining Therapies: A Systematic Review
por: Willems, Laurent M., et al.
Publicado: (2021) -
Clinical characteristics and outcomes of patients with recurrent status epilepticus episodes
por: Bauer, Kristina, et al.
Publicado: (2023) -
Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition
por: Urban, Hans, et al.
Publicado: (2020) -
Intranasal midazolam as first‐line inhospital treatment for status epilepticus: a pharmaco‐EEG cohort study
por: Kay, Lara, et al.
Publicado: (2019) -
Neuromodulation Techniques in Children with Super-Refractory Status Epilepticus
por: Stavropoulos, Ioannis, et al.
Publicado: (2023)